Home | Business News | Browse by Publication | B | Business Wire

Cell Signaling Technology, Inc. Expands its PhosphoScan(R) Patent Portfolio.

Publication: Business Wire
Publication Date: 28-MAR-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
DANVERS, Mass. -- Cell Signaling Technology, Inc. (CST) announced today that it has obtained a notice of allowance from the U.S. Patent & Trademark Office allowing its patent entitled "Immunoaffinity Isolation of Modified Peptides from Complex Mixtures" (Rush et al., U.S. Pat. No. 7,198,896). The patented technology, which CST commercializes under the trademarks PhosphoScan([R]) and AcetylScan([R]), covers the selective isolation of a target population of post-translationally modified peptides from a...



More articles from Business Wire
LGS Offers Turnkey 2GHz Rapid Relocation Solutions to Federal Customer..., March 28, 2007
Oasys Mobile Extends Partnership with Mattel, Inc., March 28, 2007
The Sports Club Company, Inc. to Open The Sports Club/LA - Dallas at P..., March 28, 2007
Two New Fargo Card Identity Systems Unveiled by Fargo.(Company overvie..., March 28, 2007
LitePoint Receives Funding from Sequoia Capital.(Company overview), March 28, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.